BIGBEAR
PHARMACEUTICALS
Crizotinib is an oral small-molecule multi-target tyrosine kinase inhibitor, and the world’s first approved targeted antineoplastic agent for both ALK and ROS1. Its common dosage form is capsules.
AuthenticGuaranteeFast DeliveryPrivacy Copyright2024@ BIGBEAR All right reserved BIGBEAR
